Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

2011 Annual Report & Accounts and Notice of AGM

8th May 2012 07:00

RNS Number : 8069C
Sphere Medical Holding plc
08 May 2012
 



For Immediate Release

8 May 2012

 

Sphere Medical Holding plc

2011 Annual Report & Accounts and Notice of AGM

 

 

Cambridge, UK, 8 May, 2012: Sphere Medical Holding plc (AIM: SPHR.L), a leading developer of innovative monitoring and diagnostic products for the critical care setting, announces that it has published its Annual Report and Accounts for the year ended 31 December 2011. The document is available on the Company's website: www.spheremedical.com.

Sphere Medical confirms that its 2012 Annual General Meeting will be held at 10.00am on Tuesday, 29 May 2012 at Harston Mill, Harston, Cambridge CB22 7GG. The Annual General Meeting Notice was posted to shareholders on 4 May 2012.

 

For further information, please contact:

 

Sphere Medical Holding plc

Tel: +44 (0)1223 875222

Dr Stuart Hendry, Chief Executive Officer

Matthew Hall, Chief Financial Officer

Peel Hunt LLP

Tel: +44 (0) 20 7418 8900

James Steel

Dr Vijay Barathan

Buchanan

Tel: +44 (0) 20 7466 5000

Tim Anderson

Jessica Fontaine

 

www.spheremedical.com

 

 

Notes for Editors

Sphere Medical commenced trading on the AIM, a market operated by the London Stock Exchange (LSE), on 17 November 2011 having raised £14m (£12.8m net of expenses) in a placing of ordinary shares.

Sphere Medical is a UK based medical device company completing the development of a range of monitoring and diagnostic products designed to provide significant improvements in patient management in a number of hospital specialities. Sphere Medical's products are expected to allow near real time measurement of blood gases, various electrolytes and drug levels with laboratory accuracy, at the patient's bedside. This information can be used in a wide range of medical applications and is intended to enable faster clinical decision making and consequently to improve the management of patients.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLGDUIGGBGDS

Related Shares:

Sphere Medical Holding
FTSE 100 Latest
Value8,809.74
Change53.53